Molecular Partners AG (MLLCF)
OTCMKTS · Delayed Price · Currency is USD
2.250
-0.100 (-4.26%)
At close: Jan 28, 2026
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $170.9 million as of February 12, 2026. Its market cap has decreased by -13.42% in one year.
Market Cap
170.90M
Enterprise Value
37.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.25
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 443.91M to 170.90M, a decrease of -61.50%. That is a compound annual growth rate of -8.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 170.90M | 6.73% |
| Dec 30, 2025 | 160.13M | -2.96% |
| Dec 30, 2024 | 165.01M | 22.94% |
| Dec 29, 2023 | 134.22M | -38.09% |
| Dec 30, 2022 | 216.81M | -65.56% |
| Dec 30, 2021 | 629.47M | -8.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 145.24M |
| HST Global | 139.70M |
| BioStem Technologies | 105.50M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |